Menu Search
Equities

Animalcare Group plc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
WQ7:STU

Animalcare Group plc

Actions
  • Price (EUR)3.08
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change+12.41%
  • Beta0.8209
Data delayed at least 15 minutes, as of Feb 11 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Animalcare Group plc is a United Kingdom-based international veterinary sales and marketing company. Its principal activity is the development, sale and distribution of licensed veterinary pharmaceuticals to the Companion Animal, Production Animal and Equine veterinary markets. Its segments include Animalcare Europe and Randlab. Animalcare Europe segment is engaged in the development and marketing of pharmaceutical products that provide benefits to animal health across Europe and through the European International Partners network. Randlab segment is engaged in the development, manufacture, and distribution of veterinary pharmaceuticals and nutritional supplements tailored to the equine market. It also provides professional support services to equine veterinarians across Australia, New Zealand, the Middle East, and selected international markets. Its novel products include Plaqtiv+ and Daxocox. Daxocox is a long-acting stand for the treatment of osteoarthritic pain.

  • Revenue in GBP (TTM)81.07m
  • Net income in GBP2.98m
  • Incorporated1972
  • Employees201.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.